Literature DB >> 495486

Nifedipine in the treatment of Prinzmetal's (variant) angina.

S Goldberg, N Reichek, J Wilson, J W Hirshfeld, J Muller, J A Kastor.   

Abstract

The clinical response to therapy with the calcium-blocking agent nifedipine was assessed in 12 patients with variant angina pectoris who were 44 to 67 years old. Five patients had vasospasm of the left anterior descending coronary artery, and seven had spasm of a dominant right coronary artery. Before nifedipine therapy, the frequency of anginal attacks per 24 hour period ranged from 1 to 12, with ventricular tachycardia accompanying ischemic episodes in 7 of 12 patients and high grade atrioventricular block occurring in 2 patients. After therapy with nifedipine, 11 of 12 patients had initial relief of symptoms, and 7 of the 11 had long-term relief. Withdrawal of nifedipine led to recurrence of angina on six occasions in four patients. Provocative testing in the cardiac catheterization laboratory by means of the cold pressor test in one patient and ergonovine maleate in another before and after nifedipine administration showed that this agent can block both alpha adrenergic- and regonovine-induced vasospasm. Nifedipine may have a significant role in the therapy of angina caused by coronary spasm.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495486     DOI: 10.1016/0002-9149(79)90201-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

Review 1.  Vasodilator therapy in the perioperative period.

Authors:  P N Fyman; J E Cottrell; L Kushins; P A Casthely
Journal:  Can Anaesth Soc J       Date:  1986-09

Review 2.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 3.  Role of calcium antagonists in cardiovascular therapy.

Authors:  H Dargie; E Rowland; D Krikler
Journal:  Br Heart J       Date:  1981-07

4.  Intravenous nifedipine prevents ergonovine-induced myocardial ischemia in patients with stable effort angina.

Authors:  C Brunelli; P Spallarossa; G Ghigliotti; M Caudullo; M Iannetti; S Caponnetto
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

5.  Alterations in angina threshold with nifedipine during pacing induced angina.

Authors:  P H Kramer; K Chatterjee; A Schwartz; K Swedberg; J L Rouleau; D Curran; L Blevins; W W Parmley
Journal:  Br Heart J       Date:  1984-09

6.  A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.

Authors:  N S Khurmi; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol.

Authors:  E Rowland; P Razis; D Sugrue; D M Krikler
Journal:  Br Heart J       Date:  1983-10

8.  A normal coronary arteriogram in a very young man with Prinzmetal's variant angina: Case report with review of the literature.

Authors:  Alfredo Balvanera; Julio Frade; Alberto Zamora; Jose Luis Robledo
Journal:  Cardiovasc Dis       Date:  1981-12

9.  Treatment of angina pectoris with nifedipine: importance of dose titration.

Authors:  J Deanfield; C Wright; K Fox
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-07

Review 10.  The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.

Authors:  A L Soward; G L Vanhaleweyk; P W Serruys
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.